APA (7th ed.) Citation

Bitsch, R., Kurzay, A., Özbay Kurt, F. G., Torre, C. d. l., Lasser, S., Lepper, A., . . . Umansky, V. (2022). STAT3 inhibitor napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. Journal for ImmunoTherapy of Cancer, 10(3), . https://doi.org/10.1136/jitc-2021-004384

Chicago Style (17th ed.) Citation

Bitsch, Rebekka, et al. "STAT3 Inhibitor Napabucasin Abrogates MDSC Immunosuppressive Capacity and Prolongs Survival of Melanoma-bearing Mice." Journal for ImmunoTherapy of Cancer 10, no. 3 (2022). https://doi.org/10.1136/jitc-2021-004384.

MLA (9th ed.) Citation

Bitsch, Rebekka, et al. "STAT3 Inhibitor Napabucasin Abrogates MDSC Immunosuppressive Capacity and Prolongs Survival of Melanoma-bearing Mice." Journal for ImmunoTherapy of Cancer, vol. 10, no. 3, 2022, https://doi.org/10.1136/jitc-2021-004384.